Follow us on Twitter
twitter icon@FreshPatents


Elan patents

      

This page is updated frequently with new Elan-related patent applications.




 Label removal solution for low temperature and low alkaline conditions patent thumbnailLabel removal solution for low temperature and low alkaline conditions
According to the invention, the compositions and methods provide for the complete removal of synthetic glues or adhesives from a plurality of surfaces through the use of amide solvents in combination with surfactants, chelants, acidulants and/or additional bottle wash additives. Beneficially, the compositions and methods are suitable for use at lower temperatures, including below 35° c., and lower ph conditions, including from 5 to 10, from 6 to 9, and from 6 to 8, in comparison to conventional caustic-based adhesive removal compositions..
Ecolab Usa Inc.


 Anti human interleukin-1 receptor accessory protein (il1 rap) antibodies and uses thereof patent thumbnailAnti human interleukin-1 receptor accessory protein (il1 rap) antibodies and uses thereof
The present disclosure provides an antibody or an antigen-binding fragment thereof with binding specificity for human interleukin-1 receptor accessory protein (il1 rap) wherein the antibody or antigen-binding fragment is capable of inhibiting the binding of antibody ‘can04’ to human il1 rap. The disclosure further provides the use of such antibodies or an antigen-binding fragments in the treatment and/or diagnosis of il-1 associated diseases and conditions, including cancers such as acute myeloid leukemia and melanoma..
Cantargia Ab


 Method for treating cancer patent thumbnailMethod for treating cancer
The current disclosure relates to pharmaceutical combinations and compositions useful in the treatment of certain types of cancer. The disclosure also relates to methods for treatment of these types of cancer.
Stichting Het Nederlands Kanker Instituut


 Use of naratriptan in the treatment of rosacea patent thumbnailUse of naratriptan in the treatment of rosacea
Described herein is a method of using a topical, pharmaceutical composition, particularly a dermatological composition, comprising naratriptan to treat rosacea and in particular erythematotelangiectatic rosacea.. .
Galderma Research & Development


 Rna complexes that inhibit melanin production patent thumbnailRna complexes that inhibit melanin production
In certain aspects, provided herein are rna complexes (e.g., asymmetric rna complexes, such as asirnas and lasirnas) that inhibit tyrosinase expression and are therefore useful for reducing melanin production and for treating pigmentation-related disorders associated with excessive melanin production, such as melasma and age spots.. .
Olix Pharmaceuticals, Inc.


 Novel modulators of melanocortin receptors patent thumbnailNovel modulators of melanocortin receptors
R1 can be an acetyl, a glycosylated amino acid, —co—(ch2)n—ch3, or −co—(ch2)ncf3 with n ranging from 1 to 6. R2 can be an —conh2, —cooh, or —ch2oh.

 Natural and synthetic compounds for treating cancer and other diseases patent thumbnailNatural and synthetic compounds for treating cancer and other diseases
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins.
Pacific Arrow Limited


 Combination therapy with cd4 lymphocyte depletion and mtor inhibitors patent thumbnailCombination therapy with cd4 lymphocyte depletion and mtor inhibitors
The invention provides methods for treating a malignant neoplastic cell proliferative disorder or disease, comprising administering to a subject in need thereof an effective amount of an mtor inhibitor and an effective amount of a cd4 lymphocyte depleting agent. Such methods find utility in the treatment of certain subsets of malignant neoplastic cell proliferative disorders or diseases, e.g.
Cedars-sinai Medical Center


 Methods for the treatment of central nervous system (cns) disorders and mood disorders patent thumbnailMethods for the treatment of central nervous system (cns) disorders and mood disorders
Methods of treating a central nervous system (cns) disorder or mood disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (mc5r) peptide ligand in a pharmaceutically acceptable carrier is administered to the subject.
The Arizona Board Of Regents On Behalf Of The University Of Arizona


 Electrochemical cell with melanin electrode patent thumbnailElectrochemical cell with melanin electrode
An electrochemical cell includes an anode configured to produce multivalent cations during a discharge process, and a cathode comprising a catechol-bearing melanin. The cathode is configured to reversibly oxidize a catechol of the catechol-bearing melanin into a quinone by an extraction of the multivalent cation during a recharge process and reduce the quinone to the catechol by an insertion of the multivalent cation during the discharge process.
Carnegie Mellon University


Dual targeting antisense oligonucleotides as apoptotic inhibtor therapeutic compostions and methods for their use in the treatment of cancer

Provided herein are compositions, method and uses for modulating iap activity or for the treatment of cancer. The compositions comprise dual-targeting antisense oligonucleotides (daso) for administration to a cancer cell, wherein the cancer cell may be characterized by elevated expression of one of more of birc6, ciap1 or survivin.

6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors

The present invention relates to 6-aryl-4-phenylamino quinazolines of formula i wherein, r and r″ are as herein described. The present invention particularly relates to synthesis and anticancer and phoshpoinositide-3-kinase-α (pi3k-α) inhibitory activity.
Council Of Scientific & Industrial Research

Induction of thyroid iodide-handling gene expression in human cancers

Dual suppression of the map kinase and pi3k/akt pathways showed synergistic or greatly enhanced anti-melanoma cell effects, compared to suppression of a single pathway, including the inhibition of cell proliferation, transformation and invasion, induction of g0/g1 cell cycle arrest and, importantly, cell apoptosis. Remarkably, suppression of either pathway induces the expression of thyroid iodide-handling genes and dual suppression of the two pathways synergistically and robustly induces expression of these genes, accompanied by uptake of radioiodine in the cells.
The Johns Hopkins University

Zeaxanthin for tumor treatment

A composition comprising a pharmaceutically effective amount of zeaxanthin or its derivative for use in treating a malignant tumor and a method of using a pharmaceutically effective amount of zeaxanthin or its derivative either alone or together with one or more pharmaceutical agents for treating a malignant tumor. The tumor may be, but is not limited to breast cancer, cervix cancer, colon cancer, cutaneous melanoma, cutaneous squamous carcinoma, hepatocellular carcinoma, lung cancer, osteosarcoma, prostate cancer, and uveal melanoma.
The New York Eye And Ear Infirmary

Composition comprising extract of alpine wormwood

Disclosed is a composition containing an extract of alpine wormwood (artemisia umbelliformis) as an active ingredient. The composition disclosed in the present specification has the effect of reducing melanin generation, or inhibiting activation of tyrosinase due to the composition containing the extract of an alpine wormwood (artemisia umbelliformis).
Amorepacific Corporation

Anti-metalloprotease antibody for diagnosis and treatment of cancers

Expression of proteolytically active, high molecular weight adam protease is relatively increased in tumour cells that also express the putative tumour stem cell marker cd133. An antibody or antibody fragment such as 8c7 monoclonal antibody may be used to selectively bind to proteolytically active, high molecular weight adam10 protease to thereby detect tumour cells and also as a therapeutic agent for treating cancers, tumours and other malignancies inclusive of leukemia, lymphoma, lung cancer, colon cancer, adenoma, neuroblastoma, brain tumour, renal tumour, prostate cancer, sarcoma and/or melanoma..
Ludwig Institute For Cancer Research Ltd

Melanocortin-1 receptor-specific cyclic hexapeptides

Where r1, r2, r3, r4, r5, r6, r7, r8 and r9 are as defined in the claims, compositions and formulations including the hexapeptides of the foregoing formula or salts thereof, and methods of preventing, ameliorating or treating melanocortin-1 receptor-mediated or responsive diseases, indications, conditions and syndromes.. .

Methods and compositions for gene delivery to on bipolar cells

Disclosed are capsid-modified raav expression vectors, as well as infectious virions, compositions, and pharmaceutical formulations that include them. Also disclosed are methods of preparing and using novel capsid-protein-mutated raav vector constructs in a variety of diagnostic and therapeutic applications including, inter alia, as delivery agents for diagnosis, treatment, or amelioration of one or more diseases, disorders, or dysfunctions of the mammalian eye.
University Of Florida Research Foundation, Inc.

Compositions for affecting weight loss

Disclosed are compositions for affecting weight loss comprising a first compound and a second compound, where the first compound is an opioid antagonist and the second compound causes increased agonism of a melanocortin 3 receptor (mc3-r) or a melanocortin 4 receptor (mc4-r) compared to normal physiological conditions. Also disclosed are methods of affecting weight loss, increasing energy expenditure, increasing satiety in an individual, or suppressing the appetite of an individual, comprising identifying an individual in need thereof and treating that individual to antagonize opioid receptor activity and to enhance α-msh activity..
Orexigen Therapeutics, Inc.

Composition

The present invention relates to an oxidatively curable coating composition with which a formulation for use in catalysing the curing of oxidatively curable coating compositions, in particular oxidatively curable coating compositions comprising an oxidatively curable alkyd-based resin, has been contacted. The formulations described herein comprise a triazacyclononane-based chelant; a manganese (ii), (iii) or (iv) salt; and an alcohol or ketone, which alcohol or ketone typically acts as a solvent for the salt and the chelant.
Catexel Limited

Prognostic and diagnostic kits and herbal therapies for treating skin conditions, autoimmune diseases, inflammatory ailments and cancer

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a known or discovered treatment regimen along with periodic doses of an herbal combination including sheng di huang, da huang or jin yin hua or combinations thereof.. .
Sirbal Ltd.

Prognostic and diagnostic methods and herbal therapies for treating skin conditions, autoimmune diseases, inflammatory ailments and cancer

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a known or discovered treatment regimen along with periodic doses of an herbal combination including sheng di huang, da huang or jin yin hua or combinations thereof.. .
Sirbal Ltd.

Composition containing fucosterol for skin whitening or moisturizing

The present invention relates to a novel use of fucosterol and, more specifically, to a composition for skin whitening or composition for skin moisturizing, which is characterized by containing fucosterol. Fucosterol of chemical formula 1 below has an excellent whitening effect of inhibiting melanin generation and tyrosinase activity, and thus can be used as an active ingredient of a cosmetic composition for whitening, a food composition, or a pharmaceutical composition.
Industry-academic Cooperation Foundation, Yonsei University

Lithographic measuring overlay error and a device manufacturing method

A lithographic apparatus including an inspection apparatus can measure the overlay error of a target in a scribelane is measured. The overlay error of the required feature in the chip area may differ from this due to, for example, different responses to the exposure process.
Asml Netherlands B.v.

Armet as a marker for cancer

Disclosed is a method aiding in the assessment of cancer. More specifically disclosed is the use of the arginine-rich metastasized in early tumors protein (=armet) as a universal marker of different cancer types.
Roche Diagnostics Operations, Inc.

Genetically stable oncolytic rna virus, manufacturing and use thereof

In a method for manufacturing a modified enterovirus of echo 7 type by modification of native echo 7 virus, isolated by a known method from human feces and identified by genome sequence, the modification is performed initially conducting the virus adaptation in cancer cells, attenuated by anti-cancer agent dacarbazine, further passaging the modified virus in human embryonal fibroblast culture, followed by propagation in human melanoma cells and further passaging in human embryonal fibroblast culture, that was treated by ribavirin, isolation and purification by known method. The modified virus is suitable for treating various tumours..
Ditesan Ltd

Csgp4 - specific chimeric antigen receptor for cancer

Embodiments of the disclosure include methods and compositions related to chimeric antigen receptors (car) that target chondroitin sulfate proteoglycan-4 (cspg4). T cells transduced with a cspg4-specific car are effective for inhibition of particular cancer cells that express cspg4.
Baylor College Of Medicine



Elan topics:
  • Folic Acid
  • Carbon Dioxide
  • Antibodies
  • Immune Response
  • High Energy
  • Inorganic Compounds
  • Electrolysis
  • Semiconductor Material
  • Semiconductor
  • Hydrogen Production From Water
  • Female Sexual Dysfunction
  • Dysfunction
  • Sexual Dysfunction
  • Mammography
  • Radiograph


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Elan for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elan with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.7522

    file did exist - 2199

    2 - 1 - 51